Work

Mp34-16 a Novel Androgen Receptor (ar) Antagonist Jj-450 Inhibits Enzalutamide-resistant Mutant Ar F876l

Year: 2019

Type: article

Abstract: SPARTAN, a randomized phase 3 placebo (PBO)-controlled study in pts with high-risk e502

Source: The Journal of Urology

DOI: 10.1097/01.ju.0000555906.62685.c2

Authors: Zeyu Wu*, Zhenyu Yang, Laura Pascal, Keita Takubo, Joel Nelson, Peter Wipf, Zhou Wang

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, UPMC Enterprises, National Institutes of Health, National Cancer Institute, DOD Prostate Cancer Research Program

Awards: G1080240078, G1732116751, G194080407, G2438032066, G323416294, G4119534169, G4245701555, G5382802896, G5850682332, G741073515, G7679969642

OpenAlex ID: W2941452028

FWCI:

Cites:

Cited by:

Related to: 10